These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 8191874

  • 21. Polyneuropathy with monoclonal gammopathy: glycolipids are frequently antigens for IgM paraproteins.
    Ilyas AA, Quarles RH, Dalakas MC, Brady RO.
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6697-700. PubMed ID: 2413445
    [Abstract] [Full Text] [Related]

  • 22. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS.
    Suarez GA, Kelly JJ.
    Neurology; 1993 Jul; 43(7):1304-8. PubMed ID: 8327128
    [Abstract] [Full Text] [Related]

  • 23. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
    Steiner N, Schwärzler A, Göbel G, Löscher W, Wanschitz J, Gunsilius E.
    Oncotarget; 2017 Jan 17; 8(3):5081-5091. PubMed ID: 27974705
    [Abstract] [Full Text] [Related]

  • 24. An update on monoclonal gammopathy and neuropathy.
    Ramchandren S, Lewis RA.
    Curr Neurol Neurosci Rep; 2012 Feb 17; 12(1):102-10. PubMed ID: 22090258
    [Abstract] [Full Text] [Related]

  • 25. [Polyneuropathies and monoclonal gammopathies, so-called benign].
    Vallat JM, Jauberteau MO, Arbo-Oze-de-Morvil C, Tabaraud F.
    Rev Prat; 1992 Jan 01; 42(1):43-5. PubMed ID: 1314413
    [Abstract] [Full Text] [Related]

  • 26. Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases.
    Ellie E, Vital A, Steck A, Boiron JM, Vital C, Julien J.
    J Neurol; 1996 Jan 01; 243(1):34-43. PubMed ID: 8869385
    [Abstract] [Full Text] [Related]

  • 27. Kappa light chain restriction correlates with peripheral neuropathy in patients with non-IgM monoclonal gammopathy of undetermined significance.
    Dasanu CA, Kaur J, Farrell S, Plaxe SC.
    Eur J Haematol; 2022 Jan 01; 108(1):86-87. PubMed ID: 34624145
    [No Abstract] [Full Text] [Related]

  • 28. [Polyneuropathy associated with monoclonal gammapathy of undetermined significance].
    Mellibovsky Saidler L, Roquer González J, Corominas Torres JM, Tomás Cedó R, Pérez Vila E, Guelar Grimberg A, Coll Daroca J.
    Med Clin (Barc); 1988 Jun 11; 91(3):88-92. PubMed ID: 2845203
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS).
    Kvarnstrom M, Sidorova E, Nilsson J, Ekerfelt C, Vrethem M, Soderberg O, Johansson M, Rosen A, Ernerudh J.
    Clin Exp Immunol; 2002 Feb 11; 127(2):255-62. PubMed ID: 11876747
    [Abstract] [Full Text] [Related]

  • 31. [Polyneuropathy associated with monoclonal gammopathy of undetermined significance].
    Moth Henriksen M, Kolmos EB, Abildgaard N, Schrøder HD, Sindrup S.
    Ugeskr Laeger; 2012 Oct 22; 174(43):2630-4. PubMed ID: 23095652
    [Abstract] [Full Text] [Related]

  • 32. Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management.
    Chaudhry HM, Mauermann ML, Rajkumar SV.
    Mayo Clin Proc; 2017 May 22; 92(5):838-850. PubMed ID: 28473042
    [Abstract] [Full Text] [Related]

  • 33. [Neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein (MAG) antibody].
    Kawagashira Y, Koike H, Sobue G.
    Nihon Rinsho; 2015 Sep 22; 73 Suppl 7():440-5. PubMed ID: 26480739
    [No Abstract] [Full Text] [Related]

  • 34. [Peripheral neuropathy with monoclonal gammopathy].
    Meier T, Meyer M.
    Schweiz Med Wochenschr; 1990 Mar 24; 120(12):417-25. PubMed ID: 2157280
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [A case of severe chronic inflammatory demyelinating polyradiculoneuropathy with monoclonal gammopathy of undetermined significance with alternating immunoglobulin class to IgM from IgA].
    Hayashi S, Nagamine S, Makioka K, Kusunoki S, Okamoto K.
    Rinsho Shinkeigaku; 2016 Sep 29; 56(9):593-9. PubMed ID: 27580763
    [Abstract] [Full Text] [Related]

  • 37. Treatment for IgG and IgA paraproteinaemic neuropathy.
    Allen D, Lunn MP, Niermeijer J, Nobile-Orazio E.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD005376. PubMed ID: 17253554
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Monoclonal gammopathy and neuropathy.
    Lozeron P, Adams D.
    Curr Opin Neurol; 2007 Oct 24; 20(5):536-41. PubMed ID: 17885441
    [Abstract] [Full Text] [Related]

  • 40. Immunostaining of skin biopsy adds no diagnostic value in MGUS-associated peripheral neuropathy.
    Al-Zuhairy A, Schrøder HD, Plesner T, Abildgaard N, Sindrup SH.
    J Neurol Sci; 2015 Feb 15; 349(1-2):60-4. PubMed ID: 25582978
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.